Human disease
myelodysplastic syndrome
Mondo defines it as: “A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 2870 | Myelodysplastic syndrome | Both routes | 2 | Human disease |
42.0
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Azacitidine | None of these genes | Approved |
| Cedazuridine | None of these genes | Approved |
| Clofarabine | None of these genes | Approved |
| Decitabine | None of these genes | Approved |
| Deferasirox | None of these genes | Approved |
| Epoetin Alfa | None of these genes | Approved |
| Filgrastim | None of these genes | Approved |
| Imetelstat | None of these genes | Approved |
| Lenalidomide | None of these genes | Approved |
| Luspatercept | None of these genes | Approved |
| Alemtuzumab | None of these genes | Phase 3 |
| Antilymphocyte Immunoglobulin (Horse) | None of these genes | Phase 3 |
| Apg-2575 | None of these genes | Phase 3 |
| Arsenic Trioxide | None of these genes | Phase 3 |
| Asparaginase | None of these genes | Phase 3 |
| Asparaginase Erwinia Chrysanthemi | None of these genes | Phase 3 |
| Busulfan | None of these genes | Phase 3 |
| Calcitriol | None of these genes | Phase 3 |
| Caspofungin | None of these genes | Phase 3 |
| Cladribine | None of these genes | Phase 3 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 3 |
| Cyclosporine | None of these genes | Phase 3 |
| Cytarabine | None of these genes | Phase 3 |
| Darbepoetin Alfa | None of these genes | Phase 3 |
| Daunorubicin | None of these genes | Phase 3 |
| Dexamethasone | None of these genes | Phase 3 |
| Elritercept | None of these genes | Phase 3 |
| Enasidenib | None of these genes | Phase 3 |
| Epoetin Beta | None of these genes | Phase 3 |
| Eprenetapopt | None of these genes | Phase 3 |
| Etelcalcetide | None of these genes | Phase 3 |
| Etoposide | None of these genes | Phase 3 |
| Fludarabine | None of these genes | Phase 3 |
| Fludarabine Phosphate | None of these genes | Phase 3 |
| Gemtuzumab Ozogamicin | None of these genes | Phase 3 |
| Gilteritinib | None of these genes | Phase 3 |
| Glasdegib | None of these genes | Phase 3 |
| Guadecitabine | None of these genes | Phase 3 |
| Hydrocortisone | None of these genes | Phase 3 |
| Hydroxyurea | None of these genes | Phase 3 |
| Idarubicin | None of these genes | Phase 3 |
| Isotretinoin | None of these genes | Phase 3 |
| Ivosidenib | None of these genes | Phase 3 |
| Lemzoparlimab | None of these genes | Phase 3 |
| Lenograstim | None of these genes | Phase 3 |
| Lonafarnib | None of these genes | Phase 3 |
| Magrolimab | None of these genes | Phase 3 |
| Melphalan | None of these genes | Phase 3 |
| Methotrexate | None of these genes | Phase 3 |
| Midostaurin | None of these genes | Phase 3 |
| Mitoxantrone | None of these genes | Phase 3 |
| Mycophenolate Mofetil | None of these genes | Phase 3 |
| Omacetaxine Mepesuccinate | None of these genes | Phase 3 |
| Omidubicel | None of these genes | Phase 3 |
| Panobinostat | None of these genes | Phase 3 |
| Pegfilgrastim | None of these genes | Phase 3 |
| Pevonedistat | None of these genes | Phase 3 |
| Recombinant Human Thrombopoietin | None of these genes | Phase 3 |
| Rigosertib | None of these genes | Phase 3 |
| Rituximab | None of these genes | Phase 3 |
| Roxadustat | None of these genes | Phase 3 |
| Sabatolimab | None of these genes | Phase 3 |
| Semustine | None of these genes | Phase 3 |
| Sirolimus | None of these genes | Phase 3 |
| Tacrolimus Anhydrous | None of these genes | Phase 3 |
| Tamibarotene | None of these genes | Phase 3 |
| Thalidomide | None of these genes | Phase 3 |
| Thioguanine | None of these genes | Phase 3 |
| Thiotepa | None of these genes | Phase 3 |
| Treosulfan | None of these genes | Phase 3 |
| Tretinoin | None of these genes | Phase 3 |
| Valspodar | None of these genes | Phase 3 |
| Venetoclax | None of these genes | Phase 3 |
| Eltrombopag | None of these genes | Phase 2/3 |
| Galunisertib | None of these genes | Phase 2/3 |
| Imetelstat Sodium | None of these genes | Phase 2/3 |
| Methylprednisolone | None of these genes | Phase 2/3 |
| Nivolumab | None of these genes | Phase 2/3 |
| Quizartinib | None of these genes | Phase 2/3 |
| Rafutrombopag | None of these genes | Phase 2/3 |
| Rivogenlecleucel | None of these genes | Phase 2/3 |
| Sorafenib | None of these genes | Phase 2/3 |
| Tipifarnib | None of these genes | Phase 2/3 |
| Vosaroxin | None of these genes | Phase 2/3 |
| 2-Mercaptoethanesulfonic Acid | None of these genes | Phase 2 |
| Adavosertib | None of these genes | Phase 2 |
| Aflibercept | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alisertib | None of these genes | Phase 2 |
| Alovudine | None of these genes | Phase 2 |
| Amifostine | None of these genes | Phase 2 |
| Ammonium Trichlorotellurate | None of these genes | Phase 2 |
| Amsacrine | None of these genes | Phase 2 |
| Ar-67 | None of these genes | Phase 2 |
| Ascorbic Acid | None of these genes | Phase 2 |
| Aspacytarabine | None of these genes | Phase 2 |
| Atorvastatin | None of these genes | Phase 2 |
| Autologous Cord Blood | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Belinostat | None of these genes | Phase 2 |
| Bemcentinib | None of these genes | Phase 2 |
| Bevacizumab | None of these genes | Phase 2 |
| Bexarotene | None of these genes | Phase 2 |
| Bezafibrate | None of these genes | Phase 2 |
| Birinapant | None of these genes | Phase 2 |
| Bomedemstat | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Briquilimab | None of these genes | Phase 2 |
| Bryostatin 1 | None of these genes | Phase 2 |
| Calcifediol Anhydrous | None of these genes | Phase 2 |
| Camidanlumab Tesirine | None of these genes | Phase 2 |
| Canakinumab | None of these genes | Phase 2 |
| Carboplatin | None of these genes | Phase 2 |
| Cdc-801 | None of these genes | Phase 2 |
| Cediranib | None of these genes | Phase 2 |
| Cholecalciferol | None of these genes | Phase 2 |
| Cisplatin | None of these genes | Phase 2 |
| Cpi 613 | None of these genes | Phase 2 |
| Cusatuzumab | None of these genes | Phase 2 |
| Daclizumab | None of these genes | Phase 2 |
| Danazol | None of these genes | Phase 2 |
| Dapagliflozin | None of these genes | Phase 2 |
| Daratumumab | None of these genes | Phase 2 |
| Dasatinib Anhydrous | None of these genes | Phase 2 |
| Deferiprone | None of these genes | Phase 2 |
| Dexrazoxane | None of these genes | Phase 2 |
| Doxorubicin | None of these genes | Phase 2 |
| Durvalumab | None of these genes | Phase 2 |
| E-7820 | None of these genes | Phase 2 |
| Emavusertib | None of these genes | Phase 2 |
| Entinostat | None of these genes | Phase 2 |
| Epacadostat | None of these genes | Phase 2 |
| Erlotinib | None of these genes | Phase 2 |
| Etanercept | None of these genes | Phase 2 |
| Everolimus | None of these genes | Phase 2 |
| Ezatiostat | None of these genes | Phase 2 |
| Flotetuzumab | None of these genes | Phase 2 |
| Gedatolisib | None of these genes | Phase 2 |
| Gemtuzumab | None of these genes | Phase 2 |
| Glycerol Phenylbutyrate | None of these genes | Phase 2 |
| H3b-8800 | None of these genes | Phase 2 |
| Hematin | None of these genes | Phase 2 |
| Hma | None of these genes | Phase 2 |
| Hydralazine | None of these genes | Phase 2 |
| Imatinib | None of these genes | Phase 2 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 2 |
| Indisulam | None of these genes | Phase 2 |
| Infliximab | None of these genes | Phase 2 |
| Interferon Alfa-2b | None of these genes | Phase 2 |
| Interferon Gamma-1b | None of these genes | Phase 2 |
| Interleukin-12 Human Recombinant | None of these genes | Phase 2 |
| Ipilimumab | None of these genes | Phase 2 |
| Ker-047 | None of these genes | Phase 2 |
| Laromustine | None of these genes | Phase 2 |
| Leuprolide | None of these genes | Phase 2 |
| Lintuzumab | None of these genes | Phase 2 |
| Lirilumab | None of these genes | Phase 2 |
| Medroxyprogesterone Acetate | None of these genes | Phase 2 |
| Metoclopramide | None of these genes | Phase 2 |
| Mocetinostat | None of these genes | Phase 2 |
| Molgramostim | None of these genes | Phase 2 |
| Molibresib | None of these genes | Phase 2 |
| Momelotinib | None of these genes | Phase 2 |
| Monalizumab | None of these genes | Phase 2 |
| Motixafortide | None of these genes | Phase 2 |
| Nerofe | None of these genes | Phase 2 |
| Nicotinamide Riboside | None of these genes | Phase 2 |
| Nogapendekin Alfa | None of these genes | Phase 2 |
| Obatoclax | None of these genes | Phase 2 |
| Octanoic Acid | None of these genes | Phase 2 |
| Olaparib | None of these genes | Phase 2 |
| Olutasidenib | None of these genes | Phase 2 |
| Oxiglutatione | None of these genes | Phase 2 |
| Pacritinib | None of these genes | Phase 2 |
| Paricalcitol | None of these genes | Phase 2 |
| Pembrolizumab | None of these genes | Phase 2 |
| Pentostatin | None of these genes | Phase 2 |
| Perifosine | None of these genes | Phase 2 |
| Phenylbutanoic Acid | None of these genes | Phase 2 |
| Pomalidomide | None of these genes | Phase 2 |
| Pracinostat | None of these genes | Phase 2 |
| Pravastatin | None of these genes | Phase 2 |
| Prednisone | None of these genes | Phase 2 |
| Pterostilbene | None of these genes | Phase 2 |
| Regramostim | None of these genes | Phase 2 |
| Ridaforolimus | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Romiplostim | None of these genes | Phase 2 |
| Ropeginterferon Alfa-2b | None of these genes | Phase 2 |
| Rosuvastatin | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| Sapacitabine | None of these genes | Phase 2 |
| Sargramostim | None of these genes | Phase 2 |
| Sel-120 Free Base | None of these genes | Phase 2 |
| Selinexor | None of these genes | Phase 2 |
| Sephb4-Hsa | None of these genes | Phase 2 |
| Sodium Stibogluconate | None of these genes | Phase 2 |
| Sotatercept | None of these genes | Phase 2 |
| Sp-420 | None of these genes | Phase 2 |
| Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Crm197 | None of these genes | Phase 2 |
| Sunitinib | None of these genes | Phase 2 |
| Talacotuzumab | None of these genes | Phase 2 |
| Talmapimod | None of these genes | Phase 2 |
| Tebapivat | None of these genes | Phase 2 |
| Temozolomide | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Tomaralimab | None of these genes | Phase 2 |
| Topotecan | None of these genes | Phase 2 |
| Tosedostat | None of these genes | Phase 2 |
| Trametinib | None of these genes | Phase 2 |
| Troculeucel | None of these genes | Phase 2 |
| Ustekinumab | None of these genes | Phase 2 |
| Vadastuximab Talirine | None of these genes | Phase 2 |
| Valproic Acid | None of these genes | Phase 2 |
| Vatalanib | None of these genes | Phase 2 |
| Vibecotamab | None of these genes | Phase 2 |
| Vincristine | None of these genes | Phase 2 |
| Vismodegib | None of these genes | Phase 2 |
| Volasertib | None of these genes | Phase 2 |
| Vorinostat | None of these genes | Phase 2 |
| Zeprumetostat | None of these genes | Phase 2 |
| Ab-8939 | None of these genes | Phase 1/2 |
| Acadesine | None of these genes | Phase 1/2 |
| Aclarubicin | None of these genes | Phase 1/2 |
| Adakitug | None of these genes | Phase 1/2 |
| Alrizomadlin | None of these genes | Phase 1/2 |
| Alvocidib | None of these genes | Phase 1/2 |
| At-9283 | None of these genes | Phase 1/2 |
| Atezolizumab | None of these genes | Phase 1/2 |
| Axatilimab | None of these genes | Phase 1/2 |
| Azd-5153 | None of these genes | Phase 1/2 |
| Azd-5991 | None of these genes | Phase 1/2 |
| Bendamustine | None of these genes | Phase 1/2 |
| Beroterkib Anhydrous | None of these genes | Phase 1/2 |
| Bexmarilimab | None of these genes | Phase 1/2 |
| Cg-200745 | None of these genes | Phase 1/2 |
| Curcumin | None of these genes | Phase 1/2 |
| Cyc-065 | None of these genes | Phase 1/2 |
| Digoxin | None of these genes | Phase 1/2 |
| Dordaviprone | None of these genes | Phase 1/2 |
| Dubermatinib | None of these genes | Phase 1/2 |
| E-6201 | None of these genes | Phase 1/2 |
| Elranatamab | None of these genes | Phase 1/2 |
| Eltanexor | None of these genes | Phase 1/2 |
| Entospletinib | None of these genes | Phase 1/2 |
| Ergocalciferol | None of these genes | Phase 1/2 |
| Evorpacept | None of these genes | Phase 1/2 |
| Ficlatuzumab | None of these genes | Phase 1/2 |
| Filanesib | None of these genes | Phase 1/2 |
| Ganetespib | None of these genes | Phase 1/2 |
| Gsk2879552 | None of these genes | Phase 1/2 |
| Histamine | None of these genes | Phase 1/2 |
| Hydroxychloroquine | None of these genes | Phase 1/2 |
| Incb-047986 | None of these genes | Phase 1/2 |
| Incb-059872 | None of these genes | Phase 1/2 |
| Inobrodib | None of these genes | Phase 1/2 |
| Interleukin-7 | None of these genes | Phase 1/2 |
| Itraconazole | None of these genes | Phase 1/2 |
| Ixazomib | None of these genes | Phase 1/2 |
| Kb-004 | None of these genes | Phase 1/2 |
| Lb-100 | None of these genes | Phase 1/2 |
| Leflunomide | None of these genes | Phase 1/2 |
| Melk Inhibitor | None of these genes | Phase 1/2 |
| Muromonab-Cd3 | None of these genes | Phase 1/2 |
| Nefextinib | None of these genes | Phase 1/2 |
| Nidanilimab | None of these genes | Phase 1/2 |
| Ocifisertib | None of these genes | Phase 1/2 |
| Ombipepimut-S | None of these genes | Phase 1/2 |
| Oxaliplatin | None of these genes | Phase 1/2 |
| Oxi-4503 | None of these genes | Phase 1/2 |
| Palifermin | None of these genes | Phase 1/2 |
| Pelabresib | None of these genes | Phase 1/2 |
| Pemrametostat | None of these genes | Phase 1/2 |
| Phorbol Myristate Acetate | None of these genes | Phase 1/2 |
| Plerixafor | None of these genes | Phase 1/2 |
| Ponatinib | None of these genes | Phase 1/2 |
| Posaconazole | None of these genes | Phase 1/2 |
| Pr1 Leukemia Peptide Vaccine | None of these genes | Phase 1/2 |
| Prexigebersen | None of these genes | Phase 1/2 |
| Revumenib | None of these genes | Phase 1/2 |
| Rimiducid | None of these genes | Phase 1/2 |
| Rogocekib | None of these genes | Phase 1/2 |
| Safimestomig | None of these genes | Phase 1/2 |
| Samalizumab | None of these genes | Phase 1/2 |
| Seclidemstat | None of these genes | Phase 1/2 |
| Sonrotoclax | None of these genes | Phase 1/2 |
| Tamnorzatinib | None of these genes | Phase 1/2 |
| Teclistamab | None of these genes | Phase 1/2 |
| Telaglenastat | None of these genes | Phase 1/2 |
| Timdarpacept | None of these genes | Phase 1/2 |
| Tranylcypromine | None of these genes | Phase 1/2 |
| Ubidecarenone | None of these genes | Phase 1/2 |
| Ulixertinib | None of these genes | Phase 1/2 |
| Vactosertib | None of these genes | Phase 1/2 |
| Zilurgisertib | None of these genes | Phase 1/2 |
| Abaloparatide | None of these genes | Phase 1 |
| Alpelisib | None of these genes | Phase 1 |
| Amv-564 | None of these genes | Phase 1 |
| Anzurstobart | None of these genes | Phase 1 |
| Apto-253 | None of these genes | Phase 1 |
| Apvo-436 | None of these genes | Phase 1 |
| Asunercept | None of these genes | Phase 1 |
| Basiliximab | None of these genes | Phase 1 |
| Binimetinib | None of these genes | Phase 1 |
| Birabresib | None of these genes | Phase 1 |
| Bisantrene | None of these genes | Phase 1 |
| Bms-214662 | None of these genes | Phase 1 |
| Btx-A51 | None of these genes | Phase 1 |
| Calaspargase Pegol | None of these genes | Phase 1 |
| Calcium | None of these genes | Phase 1 |
| Camibirstat | None of these genes | Phase 1 |
| Cc-11006 | None of these genes | Phase 1 |
| Cenersen | None of these genes | Phase 1 |
| Ceralasertib | None of these genes | Phase 1 |
| Cirtuvivint | None of these genes | Phase 1 |
| Crenolanib | None of these genes | Phase 1 |
| Danvatirsen | None of these genes | Phase 1 |
| Defactinib | None of these genes | Phase 1 |
| Dolastatin-10 | None of these genes | Phase 1 |
| Doxecitine | None of these genes | Phase 1 |
| Dvx-201 | None of these genes | Phase 1 |
| Edetate Calcium Disodium Anhydrous | None of these genes | Phase 1 |
| Eganelisib | None of these genes | Phase 1 |
| Enzomenib | None of these genes | Phase 1 |
| Eragidomide | None of these genes | Phase 1 |
| Evofosfamide | None of these genes | Phase 1 |
| Exatecan | None of these genes | Phase 1 |
| Fostamatinib | None of these genes | Phase 1 |
| Galinpepimut-S | None of these genes | Phase 1 |
| Gentulizumab | None of these genes | Phase 1 |
| Gimatecan | None of these genes | Phase 1 |
| Gti-2040 | None of these genes | Phase 1 |
| Hiltonol | None of these genes | Phase 1 |
| Hu8f4 | None of these genes | Phase 1 |
| Iadademstat | None of these genes | Phase 1 |
| Ibi-188 | None of these genes | Phase 1 |
| Ibrutinib | None of these genes | Phase 1 |
| Idh305 | None of these genes | Phase 1 |
| Ilorasertib | None of these genes | Phase 1 |
| Irofulven | None of these genes | Phase 1 |
| Ispinesib | None of these genes | Phase 1 |
| Jnj-64264681 | None of these genes | Phase 1 |
| Kw-2449 | None of these genes | Phase 1 |
| Leucovorin | None of these genes | Phase 1 |
| Lgh-447 | None of these genes | Phase 1 |
| Lurbinectedin | None of these genes | Phase 1 |
| Luxeptinib | None of these genes | Phase 1 |
| Mik-665 | None of these genes | Phase 1 |
| Milademetan | None of these genes | Phase 1 |
| Navitoclax | None of these genes | Phase 1 |
| Nisevokitug | None of these genes | Phase 1 |
| Nrx195183 | None of these genes | Phase 1 |
| Onametostat | None of these genes | Phase 1 |
| Palbociclib | None of these genes | Phase 1 |
| Pegzilarginase | None of these genes | Phase 1 |
| Pexmetinib | None of these genes | Phase 1 |
| Plx-51107 | None of these genes | Phase 1 |
| Prexasertib | None of these genes | Phase 1 |
| Pyrimethamine | None of these genes | Phase 1 |
| Quisinostat | None of these genes | Phase 1 |
| Rebeccamycin | None of these genes | Phase 1 |
| Regorafenib | None of these genes | Phase 1 |
| Rezatapopt | None of these genes | Phase 1 |
| Rezetamig | None of these genes | Phase 1 |
| Ro-6870810 | None of these genes | Phase 1 |
| S-55746 | None of these genes | Phase 1 |
| Safimaltib | None of these genes | Phase 1 |
| Sar-103168 | None of these genes | Phase 1 |
| Selumetinib | None of these genes | Phase 1 |
| Sertraline | None of these genes | Phase 1 |
| Siremadlin | None of these genes | Phase 1 |
| Sjg-136 | None of these genes | Phase 1 |
| Sodium Salicylate | None of these genes | Phase 1 |
| Sonidegib | None of these genes | Phase 1 |
| Spartalizumab | None of these genes | Phase 1 |
| Succimer | None of these genes | Phase 1 |
| Sulanemadlin | None of these genes | Phase 1 |
| Sx-682 | None of these genes | Phase 1 |
| Tagraxofusp | None of these genes | Phase 1 |
| Tak-243 | None of these genes | Phase 1 |
| Talazoparib | None of these genes | Phase 1 |
| Talfirastide | None of these genes | Phase 1 |
| Tanespimycin | None of these genes | Phase 1 |
| Tapotoclax | None of these genes | Phase 1 |
| Tas-1553 | None of these genes | Phase 1 |
| Tetrahydrouridine | None of these genes | Phase 1 |
| Tocilizumab | None of these genes | Phase 1 |
| Tremelimumab | None of these genes | Phase 1 |
| Triapine | None of these genes | Phase 1 |
| Ucn-01 | None of these genes | Phase 1 |
| Uproleselan | None of these genes | Phase 1 |
| Veliparib | None of these genes | Phase 1 |
| Yttrium | None of these genes | Phase 1 |
| Zedenoleucel | None of these genes | Phase 1 |
| Deferoxamine | None of these genes | Unknown |
| Fluconazole | None of these genes | Unknown |
| Interferon | None of these genes | Unknown |
| Interferon Alfa | None of these genes | Unknown |
| Niraparib | None of these genes | Unknown |
| Peginterferon Alfa-2a | None of these genes | Unknown |
| Propranolol | None of these genes | Unknown |
| Rucaparib | None of these genes | Unknown |
| Voriconazole | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.